Results 41 to 50 of about 21,670 (174)

The improvement chest x-ray after carvedilol therapy in heart failure due to left to right shunt, congenital heart disease [PDF]

open access: yes, 2017
Background: Heart failure due to left to right shunt congenital heart defect will increase pulmonary blood flow and cause volume overload. This condition activated the sympathetic nervous system and the renin-angiotensin-aldosteron system.
Taufiq Hidayat, -   +4 more
core   +1 more source

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results

open access: yesHeart International, 2014
Background Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk, correlating with risk of heart disease, silent myocardial ischemia or sudden cardiac death.
Heather L. Bloom   +2 more
doaj   +1 more source

Mutual Inhibition between Carvedilol Enantiomers during Racemate Glucuronidation Mediated by Human Liver and Intestinal Microsomes [PDF]

open access: yes, 2012
Carvedilol is administered orally as a racemic mixture of R(+)- and S(-)-enantiomers for treatment of angina pectoris, hypertension and chronic heart failure.
Takekuma, Yoh   +2 more
core   +1 more source

Synthesis and Characterization of Carvedilol-Etched Halloysite Nanotubes Composites with Enhanced Drug Solubility and Dissolution Rate

open access: yes, 2023
Carvedilol is a poorly water-soluble drug employed to treat chronic heart failure. In this study, we synthesize new carvedilol-etched halloysite nanotubes (HNTs) composites to enhance solubility and dissolution rate.
Debora Maria Conti   +13 more
core   +1 more source

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study.
S. Y. Martsevich   +26 more
doaj   +3 more sources

A scoping review of adverse events associated with concomitant beta‐adrenoreceptor blockers and selective serotonin reuptake inhibitors

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Beta‐adrenoreceptor blockers (beta‐blockers) and selective serotonin reuptake inhibitors (SSRIs) are commonly used medications and often used together, such as for the treatment of anxiety. However, there is no recent review of any potential adverse events related to concomitant use of medicines from each group.
Ziyi Cai   +10 more
wiley   +1 more source

Aplicação de estratégias no estado sólido visando ao aumento da solubilidade dos farmacos: cloridrato de terbinafina, carvedilol e nevirapina [PDF]

open access: yes, 2014
Tese (doutorado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2014Em medicamentos administrados via oral, as características físico-químicas dos fármacos estão diretamente ...
Kuminek, Gislaine
core  

Evaluation of Carvedilol in Prevention of First Attack of Variceal Hemorrhage in Patients with Liver Cirrhosis [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2012
Background and study aim: Carvedilol has beneficial effects on splanchnic haemodynamics following acute and chronic administration in cirrhosis. The aim of this study is to evaluate the role of carvedilol in prevention of first variceal bleeding in ...
Hosam Dawod   +3 more
doaj   +1 more source

A Precise Activity System for Pharmacogenetics Based on Estimation of CYP2D6 Allelic Percentage Activity from the International CEPAM Database

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The polymorphic enzyme CYP2D6 contributes to the metabolism of many frequently prescribed drugs, causing substantial variability in drug exposure and treatment outcomes. Genotype‐based dosing recommendations currently rely on drug‐agnostic categorical CYP2D6 allele activity values (AVs), potentially leading to imprecise CYP2D6 phenotype classification ...
Fenja Klima   +90 more
wiley   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy